Plasma hyaluronan and collateral development in patients with coronary artery disease

Coronary Artery Disease

Volumn 21, Issue 4, 2010, Pages 228-232

  Xi, Weiwei ^a   Zhou, Ying ^a   Lv, Shumin ^a   Gao, Qinqin ^a   Bu, Gang ^a   Wang, Yuxing ^a   Cheng, Gang ^a   Xu, Geng ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Atherosclerosis; Coronary artery disease; Coronary collateral; Hyaluronan

Indexed keywords

HYALURONIC ACID;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD LEVEL; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COLLATERAL CIRCULATION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYALURONIC ACID; MALE; MIDDLE AGED;

EID: 77952241305     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e328338ccf3     Document Type: Article

References (23)

1. Packard RR, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 2008; 54:24-38.
2. Berry C, Balachandran KP, L'Allier PL, Lesperance J, Bonan R, Oldroyd KG. Importance of collateral circulation in coronary heart disease. Eur Heart J 2007; 28:278-291.
3. Pascotto M, Wei K, Micari A, Bragadeesh T, Goodman NC, Kaul S. Phasic changes in arterial blood volume is influenced by collateral blood flow: implications for the quantification of coronary stenosis at rest. Heart 2007; 93:438-443.
4. Kocaman SA, Arslan U, Tavil Y, Okuyan H, Abaci A, Cengel A. Increased circulating monocyte count is related to good collateral development in coronary artery disease. Atherosclerosis 2008; 197:753-756.
5. Schultz A, Lavie L, Hochberg I, Beyar R, Stone T, Skorecki K, et al. Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation. Circulation 1999; 100:547-552.
6. Mitsuma W, Kodama M, Hirono S, Ito M, Ramadan MM, Tanaka K, et al. Angiopoietin-1, angiopoietin-2 and tie-2 in the coronary circulation of patients with and without coronary collateral vessels. Circ J 2007; 71:343-347.
7. Slevin M, Krupinski J, Gaffney J, Matou S, West D, Delisser H, et al. Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol 2007; 26:58-68.
8. Stern R, Asari AA, Sugahara KN. Hyaluronan fragments: an information-rich system. Eur J Cell Biol 2006; 85:699-715.
9. Girish KS, Kemparaju K. The magic glue hyaluronan and its eraser hyaluronidase: a biological overview. Life Sci 2007; 80:1921-1943.
10. Slevin M, Kumar S, Gaffney J. Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J Biol Chem 2002; 277:41046-41059.
11. West DC, Hampson IN, Arnold F, Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science 1985; 228:1324-1326.
12. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985; 5:587-592.
13. Verheye S, Markou CP, Salame MY, Wan B, King SB 3rd, Robinson KA, et al. Reduced thrombus formation by hyaluronic acid coating of endovascular devices. Arterioscler Thromb Vasc Biol 2000; 20:1168-1172.
14. Turley EA, Noble PW, Bourguignon LY. Signaling properties of hyaluronan receptors. J Biol Chem 2002; 277:4589-4592.
15. Kolodgie FD, Burke AP, Farb A, Weber DK, Kutys R, Wight TN, et al. Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion. Arterioscler Thromb Vasc Biol 2002; 22:1642-1648.
16. Kucur M, Karadag B, Isman FK, Ataev Y, Duman D, Karadag N, et al. Plasma hyaluronidase activity as an indicator of atherosclerosis in patients with coronary artery disease. Bratisl Lek Listy 2009; 110:21-26.
17. Slevin M, Krupinski J, Kumar S, Gaffney J. Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. Lab Invest 1998; 78:987-1003.
18. Sattar A, Rooney P, Kumar S, Pye D, West DC, Scott I, et al. Application of angiogenic oligosaccharides of hyaluronan increases blood vessel numbers in rat skin. J Invest Dermatol 1994; 103:576-579.
19. Rhodes NP. Inflammatory signals in the development of tissue-engineered soft tissue. Biomaterials 2007; 28:5131-5136.
20. Grundmann S, Schirmer SH, Hekking LH, Post JA, Ionita MG, de Groot D, et al. Endothelial glycocalyx dimensions are reduced in growing collateral arteries and modulate leukocyte adhesion in arteriogenesis. J Cell Mol Med 2009; 13:3463-3474.
21. Papakonstantinou E, Roth M, Block LH, Mirtsou-Fidani V, Argiriadis P, Karakiulakis G. The differential distribution of hyaluronic acid in the layers of human atheromatic aortas is associated with vascular smooth muscle cell proliferation and migration. Atherosclerosis 1998; 138:79-89.
22. Chai S, Chai Q, Danielsen CC, Hjorth P, Nyengaard JR, Ledet T, et al. Overexpression of hyaluronan in the tunica media promotes the development of atherosclerosis. Circ Res 2005; 96:583-591.
23. Rooney P, Wang M, Kumar P, Kumar S. Angiogenic oligosaccharides of hyaluronan enhance the production of collagens by endothelial cells. J Cell Sci 1993; 105 (Pt 1) : 213-218.